Advanced drug costs of the enlarged drug spark against jpmorgan – CVS Health (NYSE: CVS), Johnson & Johnson (Nyse: JNJ)

A lawsuit was filed against Jpmorgan Chase & Co. Jpm By its employees, who claim that the company’s descriptive drug plan is supervised Cvs Health Corp. CVSAnd he agreed to pay exorbitant prices for the drugs.

What happened: According to a report, the lawsuit claims that JPMorgan has offended health advantages. One of the examples mentioned in the case explains that the plan pays more than $ 6000 for a multiple sclerosis drug that can be purchased for about $ 30 in retail pharmacies.

Prosecutors, who include current and two former employees, claim that this “methodological mismanagement” led to the starkly enlarged drug costs “for those registered in the plan.

According to the report by Bloomberg, this lawsuit is part of an emerging pattern of similar issues against major employers such as Johnson and Johnson Jnj and Wales Vargo and Co. WFC.

These cases examine the role of employers in the costs of escalating health care in the United States and the profits of managers of pharmacy, such as CVS.

Also read: Here are the paid JPMorgan Chase for legal battles over two years for two years

The lawsuit claims that Jpmorgan has violated its credit duties under the employee’s retirement security law, which regulates the plans of adult employers. The case also highlights the cases where the JPMorgan plan from CVS Health was much higher than the prices that patients will pay without insurance.

As of now, JPMorgan did not respond to the suspension requests, and a CVS spokesman rejected the comment. The case was submitted, Seth Stenn et al v. Jpmorgan Chase & Co.

Why do it matter: This lawsuit emphasizes the continuous debate about the role of employers and pharmacy allocations for high health care costs in the United States.

The result of this issue can affect how other companies are managed with the health advantages of employees, especially with regard to the costs of prescribed medicines.

It also raises questions about the transparency and integrity of pricing in the pharmaceutical industry.

Read after that

American banks are sudden freezing accounts – here you can save you

Photo: Shutterstock